benzoyl l-arginine methyl ester has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chedid, Y; Hamza, Y; Sani, I; Ubaide, H | 1 |
| Mc Crory, PV | 1 |
| Cooke, G; Cooper, N; Fidler, S; Gardiner, T; Young, L | 1 |
| Banerjee, S; Cader, FA; Yancy, CW | 1 |
| Amarasekera, N; Manoharan, S; Sarker, P | 1 |
5 other study(ies) available for benzoyl l-arginine methyl ester and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
What about BAME? A letter to the editor on 'The socio-economic implications of the coronavirus pandemic (COVID-19): A review'.
Topics: Arginine; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Socioeconomic Factors | 2020 |
BAME and COVID-19.
Topics: Arginine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
Topics: Arginine; COVID-19; Ethnicity; Humans; London; SARS-CoV-2; State Medicine | 2021 |
To be, or not to be BAME, in the time of COVID-19: does it matter?
Topics: Arginine; COVID-19; Humans; Myocardial Infarction; Pandemics; Race Factors; SARS-CoV-2 | 2021 |
Is there a link between the prevalence of cardiovascular disease, diabetes, kidney disease, chronic obstructive pulmonary disease and malignancies and the severity of COVID-19 within the BAME population?
Topics: Arginine; Cardiovascular Diseases; Comorbidity; COVID-19; Diabetes Mellitus; Humans; Kidney Diseases; Neoplasms; Prevalence; Pulmonary Disease, Chronic Obstructive; Risk Factors; SARS-CoV-2 | 2021 |